Biodexa Pharmaceuticals Plc (BDRX)

Biodexa Pharmaceuticals Cash Flow Statement

Financials in millions GBP. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Net Income	-7.08	-7.66	-5.46	-22.19	-10.09	-15.03	-16.06	-20.16	-10.1	-8.82	Upgrade
Depreciation & Amortization	0.28	0.34	0.4	1.21	1.28	1.02	0.98	0.77	0.5	0.32	Upgrade
Share-Based Compensation	0.03	0.12	0.09	-0.4	-0.03	0	0.52	0.2	0.17	0	Upgrade
Other Operating Activities	-0.9	-0.53	-2.2	10.13	0.43	-0.8	0.15	4.45	-3.64	2.25	Upgrade
Operating Cash Flow	-7.67	-7.73	-7.17	-11.26	-8.41	-14.81	-14.41	-14.74	-13.07	-6.25	Upgrade
Capital Expenditures	-0.02	-0.04	-0.28	-0.07	-0.31	-0.22	-0.71	-1.35	-0.92	-1.03	Upgrade
Acquisitions	-	-	0	0	-0.95	9.26	0	0	-0.66	0.12	Upgrade
Change in Investments	-0.08	-0.21	0	0	0	0	0	0	0	0	Upgrade
Other Investing Activities	-0.16	0.03	-	2.64	-2.55	0	-0.76	0.15	0.05	0.01	Upgrade
Investing Cash Flow	-0.27	-0.22	-0.28	2.57	-3.81	9.04	-1.47	-1.2	-1.53	-0.91	Upgrade
Share Issuance / Repurchase	10.43	0.24	9.04	9.74	14.11	0	5.73	0	0	0	Upgrade
Debt Issued / Paid	-0.19	-0.18	-0.22	-6.44	3.41	-5.89	4.66	-0.24	-0.21	0.5	Upgrade
Other Financing Activities	-0.01	-0.02	-0.02	-0.22	1.22	-0.59	-0.11	15.49	-0.01	33.8	Upgrade
Financing Cash Flow	10.23	0.05	8.81	3.08	18.73	-6.47	10.28	15.26	-0.22	34.3	Upgrade
Exchange Rate Effect	0	0	-0.01	0.26	0.15	0.02	-0.26	0.47	0.02	0	Upgrade
Net Cash Flow	3.14	-7.22	2.52	-3.64	8.44	-10.88	-4.15	0.97	-14.17	27.94	Upgrade
Free Cash Flow	-7.69	-7.77	-7.44	-11.32	-8.72	-15.03	-15.12	-16.08	-13.99	-7.28	Upgrade
Free Cash Flow Margin	-2019.16%	-1111.30%	-1287.72%	-3300.58%	-1293.62%	-775.70%	-1528.31%	-1215.65%	-1017.38%	-4636.31%	Upgrade
Free Cash Flow Per Share	-11.07	-630.95	-944.04	-3319.49	-5700.17	-9844.13	-12414.92	-19222.23	-16719.50	-20353.11	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).